Home » Topics » Disease categories and therapies » Ear, nose and throat

Ear, nose and throat
RSS

FDA approves Otiprio for pediatric patients undergoing tympanostomy tube placement

Dec. 14, 2015

Otonomy begins enrollment in phase III trial of OTO-104 in Meniere's disease

Nov. 20, 2015

Otonomy initiates clinical development of OTO-311 for tinnitus

Nov. 17, 2015

OticPharma licenses rights to Otodyne's otitis media program

Nov. 6, 2015

Hearing loss reduction with SENS-90 in severe noise model leads to clinical development

Oct. 28, 2015

Auris Medical and King's College London to collaborate on small-molecule tinnitus therapy

Oct. 27, 2015

New company Decibel Therapeutics launched to address hearing loss

Oct. 19, 2015

Otonomy receives IND application clearance for tinnitus candidate OTO-311

Oct. 7, 2015

Otologic licenses sensory hair cell regeneration technology from Hough Ear Institute

Oct. 2, 2015

Biophysical mechanisms causing susceptibility to tinnitus identified

Sep. 17, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...